Legal & General Group’s Mesoblast MESO Stock Holding History

Legal & General Group’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-679,023	Closed	-$12.2M	–	3395
2025 Q4	$12.2M	Buy	679,023 +27,607	+4%	+$475K	﹤0.01%	1058
2025 Q3	$10.5M	Buy	+651,416	New	+$9.53M	﹤0.01%	1187

Other funds holding MESO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Legal & General Group's MESO Position: Q1 2026 in Review

Legal & General Group sold out of Mesoblast (MESO) in Q1 2026, closing a stake of 679,023 shares — an estimated $12.2M sold.

Legal & General Group first reported a position in MESO in Q3 2025 and held it in 2 quarters. The position peaked at $12.2M in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

Legal & General Group reported no remaining Mesoblast position as of Q1 2026 after selling out during the quarter.
Legal & General Group sold 679,023 Mesoblast shares in Q1 2026, an estimated $12.2M.
Legal & General Group first reported a position in Mesoblast in Q3 2025 and held it in 2 quarters.
Legal & General Group's Mesoblast position peaked at $12.2M in Q4 2025.
69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.